Zhang Chao, Wang Lu, Yang Wei, Wang Xisha, Fawcett J Paul, Sun Yantong, Gu Jingkai
Research Center for Drug Metabolism, Jilin University, Changchun, PR China.
J Pharm Biomed Anal. 2009 Aug 15;50(1):41-5. doi: 10.1016/j.jpba.2009.03.019. Epub 2009 Mar 26.
A rapid and sensitive analytical method based on high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been developed for the determination of felbinac in rat plasma, bile, urine, feces and tissue. Sample preparation involved liquid-liquid extraction with ethyl ether-dichloromethane (60:40, v/v). Chromatography of felbinac and the internal standard probenecid was performed within 2min on a Venusil MP C(18) column (100mmx4.6mm i.d., 5microm) with a mobile phase consisting of acetonitrile-5mM ammonium acetate containing 0.1% formic acid (pH 3.0) (80:20, v/v) at a flow rate of 1.2ml/min. Detection by electrospray negative ionization mass spectrometry and multiple-reaction monitoring of the transitions of felbinac at m/z 211.1-->167.0 and of probenecid at m/z 283.9-->239.9 was linear over the concentration range 5-5000ng/ml with a lower limit of quantitation of 5ng/ml using a sample volume of only 50microl. Intra- and inter-day precisions (as relative standard deviation, R.S.D.) were < or =7.3% and < or =6.4%, respectively, and accuracy (as relative error, R.E.) was in the range -2.1 to 7.4%. Recoveries and matrix effects were satisfactory in all the biological matrices examined. The method was applied to a preclinical pharmacokinetic study in rat involving a single intravenous injection of felbinac trometamol.
已开发出一种基于高效液相色谱-串联质谱(LC-MS/MS)的快速灵敏分析方法,用于测定大鼠血浆、胆汁、尿液、粪便和组织中的非布索坦。样品制备包括用乙醚-二氯甲烷(60:40,v/v)进行液-液萃取。非布索坦和内标丙磺舒在Venusil MP C(18)柱(100mm×4.6mm内径,5μm)上于2分钟内完成色谱分离,流动相为乙腈-含0.1%甲酸的5mM醋酸铵(pH 3.0)(80:20,v/v),流速为1.2ml/min。通过电喷雾负离子质谱检测,对非布索坦m/z 211.1→167.0和丙磺舒m/z 283.9→239.9的跃迁进行多反应监测,在5-5000ng/ml浓度范围内呈线性,使用仅50μl的样品体积时定量下限为5ng/ml。日内和日间精密度(以相对标准偏差,R.S.D.计)分别≤7.3%和≤6.4%,准确度(以相对误差,R.E.计)在-2.1至7.4%范围内。在所检测的所有生物基质中,回收率和基质效应均令人满意。该方法应用于大鼠的一项临床前药代动力学研究,涉及单次静脉注射非布索坦 trometamol。